AIM ImmunoTech Inc. Common Stock (NY:AIM)

AIM ImmunoTech Announces Cash Conservation Plan

November 27, 2024

AIM ImmunoTech Issues Presentation Detailing Case for Re-Electing Current Directors to Oversee Continued Momentum and Drive Strategy to Create Long-Term Value for Patients and Shareholders

November 25, 2024

Earnings Scheduled For November 15, 2024 ↗

November 15, 2024

Via Benzinga

Insights into AIM ImmunoTech's Upcoming Earnings ↗

November 14, 2024

Via Benzinga

Exploring AIM ImmunoTech's Earnings Expectations ↗

November 07, 2024

Via Benzinga

AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders

November 04, 2024

AIM stock results show that AIM ImmunoTech beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 03, 2024

Via Benzinga

AIM Stock Earnings: AIM ImmunoTech Beats EPS, Beats Revenue for Q2 2024 ↗

August 15, 2024

AIM stock results show that AIM ImmunoTech missed analyst estimates for earnings per share the first quarter of 2024.

AIM Stock Earnings: AIM ImmunoTech Misses EPS for Q1 2024 ↗

May 16, 2024

AIM stock results show that AIM ImmunoTech missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

AIM Stock Earnings: AIM ImmunoTech Misses EPS, Beats Revenue for Q4 2023 ↗

April 02, 2024

Companies Reporting Before The Bell • Ocugen (NASDAQ:OCGN) is estimated to report earnings for its fourth quarter.

Preview: AIM ImmunoTech's Earnings ↗

April 01, 2024

Via Benzinga

Preview: AIM ImmunoTech's Earnings ↗

November 14, 2023

Via Benzinga

Earnings Scheduled For April 2, 2024 ↗

April 02, 2024

Via Benzinga

Earnings Scheduled For March 26, 2024 ↗

March 26, 2024

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.

Via Benzinga

AIM ImmunoTech And 3 Other Stocks Under $3 Insiders Are Buying ↗

March 25, 2024

The Dow Jones index closed lower by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 12, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 23, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 11, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

January 09, 2024

Pre-market stock movers are worth checking out on Tuesday to catch up on all of the hottest stock market news for this morning!

AIM Shareholders Elect All Four Company Director Nominees at 2023 Annual Meeting

January 05, 2024

Delaware Court Rules in Favor of AIM ImmunoTech and Upholds Board’s Determination that Activist Group’s Nominations Are Invalid

December 29, 2023

AIM ImmunoTech Provides Update Regarding Annual Meeting

November 28, 2023

The Dow Jones closed lower by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested...

AIM ImmunoTech And 3 Other Stocks Under $1 Insiders Are Buying ↗

November 28, 2023

Via Benzinga

Topics Stocks

AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders

November 06, 2023

The Dow Jones closed lower by more than 150 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying ↗

October 02, 2023

Via Benzinga

Topics Stocks

Why Is Cancer Focused Microcap Stock AIM ImmunoTech Trading Higher Today? ↗

September 11, 2023

AIM ImmunoTech Inc (NYSE: AIM) announced that Roswell Park Comprehensive Cancer Center has reported the complete topline data from its Phase 1 study evaluating Ampligen (rintatolimod) as a component of...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 05, 2023

Via Benzinga

Why AMC Entertainment Shares Are Trading Lower By 21%; Here Are 20 Stocks Moving Premarket ↗

August 23, 2023

Gainers BioNexus Gene Lab Corp. (NASDAQ: BGLC) shares gained 48.5% to $2.05 in pre-market trading after jumping 30% on Tuesday.

Via Benzinga

AIM ImmunoTech Rejects Director Nomination Notice from Activist Group Due to Numerous Material Defects, Omissions and False and Misleading Statements

August 23, 2023